R. YILDIZ Et Al. , "The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.," 2013 ASCO ANNUAL MEETİNG , SHİCAGO, United States Of America, 2013
YILDIZ, R. Et Al. 2013. The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.. 2013 ASCO ANNUAL MEETİNG , (SHİCAGO, United States Of America).
YILDIZ, R., BÜYÜKBERBER, S., KOCA, D., KORAL, L., ÇİLTAŞ, A., ÜNAL, O. Ü., ... GÜMÜŞ, M.(2013). The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience. . 2013 ASCO ANNUAL MEETİNG, SHİCAGO, United States Of America
YILDIZ, RAMAZAN Et Al. "The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.," 2013 ASCO ANNUAL MEETİNG, SHİCAGO, United States Of America, 2013
YILDIZ, RAMAZAN Et Al. "The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.." 2013 ASCO ANNUAL MEETİNG , SHİCAGO, United States Of America, 2013
YILDIZ, R. Et Al. (2013) . "The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.." 2013 ASCO ANNUAL MEETİNG , SHİCAGO, United States Of America.
@conferencepaper{conferencepaper, author={RAMAZAN YILDIZ Et Al. }, title={The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.}, congress name={2013 ASCO ANNUAL MEETİNG}, city={SHİCAGO}, country={United States Of America}, year={2013}}